CIK: 1470741 - Address: 17199 N. Laurel Park Drive, Suite 401, Livonia, MI 48152
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret4160-2255210-2410
P%wins5033838040048

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/14/17 17:57
3/10/17
GEMPGemphire Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsLichtinger PedroMIDP.d1009.470112160D-262-12-7-3-311124
8/12/16 13:19
8/10/16
GEMPGemphire Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsLichtinger PedroMIDP.d10010.000102549D071339414
2/11/15 19:35
2/9/15
ASTAsterias Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLichtinger PedroCADOCEOP5003.90012832528D1361520-4-3-1-3-580197-2-23
6/6/13 19:04
6/4/13
BTXBiotime IncCAHealthBioPrdBiological Products, (No DiagLichtinger PedroCADP.d00.001120999%126D-17-512-4-5-3-9-160-44-7-3-32
4/10/13 21:59
4/8/13
OPTROptimer Pharmaceuticals IncHealthDrugPharmaceutical PreparationsLichtinger PedroCAHFormer CM.d1,87812.690148104D
4/10/13 21:59
4/8/13
OPTROptimer Pharmaceuticals IncHealthDrugPharmaceutical PreparationsLichtinger PedroCAHFormer CS.d-2,17414.690-148-59104D
11/19/12 19:31
11/8/12
OPTROptimer Pharmaceuticals IncHealthDrugPharmaceutical PreparationsLichtinger PedroNJOCEO,PP1009.0801112104D
4/12/12 13:09
4/11/12
BTXBiotime IncCAHealthBioPrdBiological Products, (No DiagLichtinger PedroCADP.d253.9816New6D-41-42-5-31-16-7-5-12-1-7-810-4-16
8/4/11 17:46
8/4/11
OPTROptimer Pharmaceuticals IncHealthDrugPharmaceutical PreparationsLichtinger PedroCADOCEO,PP2248.985253891D-337-13-20-22-14-9-7-3-1985645

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact